Published in J Neuroinflammation on September 11, 2006
Anti-inflammatory peptide regulates the supply of heat shock protein 70 monomers: implications for aging and age-related disease. Rejuvenation Res (2015) 1.39
Integration of cytokine biology and lipid metabolism in stroke. Front Biosci (2008) 0.92
Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroinflammation (2006) 0.91
Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties. J Inflamm (Lond) (2008) 0.91
Secreted phospholipase A2 involvement in neurodegeneration: differential testing of prosurvival and anti-inflammatory effects of enzyme inhibition. PLoS One (2012) 0.83
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J Rheumatol (2005) 1.95
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit Care Med (2005) 1.77
Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver. Pharmacol Rev (1998) 1.76
Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol (2000) 1.73
Phospholipase A(2)s in cell injury and death. J Pharmacol Exp Ther (2000) 1.52
Circulating secretory phospholipase A2 in critical illness--the importance of the intestine. Crit Care Resusc (2001) 1.45
Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J (2001) 1.44
A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. Anal Biochem (1989) 1.28
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. J Allergy Clin Immunol (2005) 1.25
Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med (2001) 1.20
Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin. J Neurosci (1998) 1.20
Phospholipase A2 inhibitors as potential anti-inflammatory agents. Curr Pharm Des (2005) 1.18
Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat (2002) 1.11
Identification of the human cDNA for new survival/evasion peptide (DSEP): studies in vitro and in vivo of overexpression by neural cells. Exp Neurol (2002) 1.09
Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. Biochim Biophys Acta (2005) 1.06
Fc gamma receptor-mediated activation of phospholipase D regulates macrophage phagocytosis of IgG-opsonized particles. J Immunol (1999) 1.06
Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation. Glia (2003) 1.05
Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues. Br J Cancer (2006) 1.01
Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells. J Immunol (2000) 1.00
Biological effects of group IIA secreted phosholipase A(2). FEBS Lett (2002) 0.92
A maternal blood-borne factor promotes survival of the developing thalamus. FASEB J (2004) 0.92
Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroinflammation (2006) 0.91
High specificity of human secretory class II phospholipase A2 for phosphatidic acid. Biochem J (1997) 0.90
Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J Leukoc Biol (2000) 0.89
Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor. J Neurotrauma (2004) 0.88
Enzyme inhibition in open systems. Superiority of uncompetitive agents. J Biol Chem (1996) 0.86
Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP. J Leukoc Biol (2003) 0.85
An update on inhibitors of human 14 kDa Type II s-PLA2 in development. Curr Pharm Des (2001) 0.83
Enzyme kinetics: partial and complete uncompetitive inhibition. Biochem Educ (2000) 0.81
A method for identification of inhibition mechanism and estimation of Ki in in vitro enzyme inhibition study. Drug Metab Dispos (2003) 0.80
Role of type IIA secretory phospholipase A2 in arachidonic acid metabolism. Adv Exp Med Biol (1999) 0.77
Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore. J Med Chem (2010) 2.12
Anti-inflammatory peptide regulates the supply of heat shock protein 70 monomers: implications for aging and age-related disease. Rejuvenation Res (2015) 1.39
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer (2007) 1.10
p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. Clin Cancer Res (2005) 1.00
Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroinflammation (2006) 0.91
Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties. J Inflamm (Lond) (2008) 0.91
Non-concerted ITS evolution, early origin and phylogenetic utility of ITS pseudogenes in Pyrus. Mol Phylogenet Evol (2008) 0.89
Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor. J Neurotrauma (2004) 0.88
Secreted phospholipase A2 involvement in neurodegeneration: differential testing of prosurvival and anti-inflammatory effects of enzyme inhibition. PLoS One (2012) 0.83
Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder. Sci Rep (2013) 0.81
BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer. Cancer Sci (2009) 0.81
Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status. Int J Cancer (2008) 0.81
Allylic and allenic halide synthesis via NbCl(5)- and NbBr(5)-mediated alkoxide rearrangements. J Org Chem (2009) 0.80
[Study on the trend of changes in fetal macrosomia in Yantai during the past 30 years]. Zhonghua Fu Chan Ke Za Zhi (2002) 0.80
The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women. Acta Oncol (2006) 0.79
Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status. Breast Cancer Res Treat (2006) 0.79
Association of p73 G4C14-to-A4T14 (GC/AT) polymorphism with breast cancer survival. Carcinogenesis (2006) 0.78
Amino acid ionic liquids as chiral ligands in ligand-exchange chiral separations. Chemistry (2009) 0.77
Alkenenitrile Transmissive Olefination: Synthesis of the Putative Lignan "Morinol I" European J Org Chem (2011) 0.77
Human breast carcinoma xenografts in nude mice. Chin Med J (Engl) (2002) 0.77
Direct Conversion of Aldehydes and Ketones to Allylic Halides by a NbX(5-)[3,3] Rearrangement. Synlett (2009) 0.76
PDLIM5 gene polymorphisms and short term antidepressant response in Chinese major depressive disorders. Int J Clin Exp Med (2013) 0.75
A Rapid Throughput Method to Extract DNA from Formalin-Fixed Paraffin-Embedded Tissues for Biomonitoring Carcinogenic DNA Adducts in Humans. Chem Res Toxicol (2017) 0.75
Layer-by-layer assembly of polyelectrolyte and nanoparticles, monitored by capillary electrophoresis. Chemistry (2009) 0.75
Subchronic olanzapine treatment decreases the expression of pancreatic glucose transporter 2 in rat pancreatic β cells. J Endocrinol Invest (2014) 0.75
Amphiphilic chitosan derivatives-based liposomes: synthesis, development, and properties as a carrier for sustained release of salidroside. J Agric Food Chem (2014) 0.75
Use of gemini surfactants as semipermanent capillary coatings in aqueous-organic solvents for capillary electrophoretic separation of inorganic anions. J Sep Sci (2009) 0.75
Construction of hierarchically porous graphitized carbon-supported NiFe layered double hydroxides with a core-shell structure as an enhanced electrocatalyst for the oxygen evolution reaction. Nanoscale (2017) 0.75